2023 | Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
| GLAND SURGERY |
2023 | Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2023 | Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis
| CANCERS |
2023 | Robot-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term comparison of outcomes
| FRONTIERS IN ONCOLOGY |
2023 | Clinical Relevance of Red Blood Cell Distribution Width (RDW) in Endometrial Cancer: A Retrospective Single-Center Experience from Korea
| CANCERS |
2023 | Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
2023 | Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
| SCIENTIFIC REPORTS |
2023 | Vaginal Cuff Dehiscence and a Guideline to Determine Treatment Strategy
| JOURNAL OF PERSONALIZED MEDICINE |
2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
| FRONTIERS IN ONCOLOGY |
2023 | LncRNA SNHG4 Modulates EMT Signal and Antitumor Effects in Endometrial Cancer through Transcription Factor SP-1
| BIOMEDICINES |
2023 | Clinical Relevance of Vaginal Cuff Dehiscence after Minimally Invasive versus Open Hysterectomy
| JOURNAL OF CLINICAL MEDICINE |
2023 | Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2023 | HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer
| ONCOLOGY REPORTS |
2023 | Clinical Relevance of Uterine Manipulation on Oncologic Outcome in Robot-Assisted versus Open Surgery in the Management of Endometrial Cancer | JOURNAL OF CLINICAL MEDICINE |
2022 | USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY? | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PROSPECTIVE MULTI-INSTITUTIONAL PHASE III TRIAL OF STANDARD OF CARE THERAPY WITH OR WITHOUT STEROTACTIC ABLATIVE RADIATION THERAPY FOR RECURRENT OVARIAN CANCER (SABR-ROC, KGOG 3064/KROG 2204) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES USING DA VINCI XI AND SP SURGICAL SYSTEM IN ENDOMETRIAL CANCER SURGICAL STAGING | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PATIENT-DERIVED ORGANOIDS AS A PRECLINICAL PLATFORM FOR PRECISION MEDICINE IN PATIENTS WITH CERVICAL CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTS | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Expression profiles of id and E2A in ovarian cancer and sup-pression of ovarian cancer by the E2A isoform E47 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Clinical relevance of red blood cell distribution as prognostic marker in endometrial carcinoma | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative images | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study
| INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues
| Obstetrics & Gynecology Science |
2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
2022 | Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
| FRONTIERS IN ONCOLOGY |
2022 | Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47
| CANCERS |
2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | GYNECOLOGIC ONCOLOGY |
2022 | Long term oncologic and reproductive outcomes after robot-assisted radical trachelectomy for early-stage cervical cancer. An international multicenter study
| GYNECOLOGIC ONCOLOGY |
2022 | Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2022 | Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer
| Obstetrics & Gynecology Science |
2022 | Long Non-coding RNA LOC285194 Promotes Epithelial Ovarian Cancer Progression via the Apoptosis Signaling Pathway
| IN VIVO |
2021 | Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
| Journal of Menopausal Medicine |
2021 | Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2021 | A combination of second trimester oral metronidazole and no sexual intercourse during second and third trimester may reduce late miscarriage and premature delivery after fertility sparing radical trachelectomy | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
2021 | LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial-mesenchymal transition
| BIOSCIENCE REPORTS |
2021 | Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component | MODERN PATHOLOGY |
2021 | Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2021 | Report from the 36th Annual Meeting of the Korean Society of Gynecologic Oncology (KSGO)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2021 | Association between PD-L1 expression and 18 F-FDG uptake in ovarian cancer | ANNALS OF NUCLEAR MEDICINE |
2021 | Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
| CANCERS |
2021 | Markedly increased risk of malignancies in women with endometriosis | GYNECOLOGIC ONCOLOGY |
2021 | Nationwide Comparison of Surgical and Oncologic Outcomes in Endometrial Cancer Patients Undergoing Robotic, Laparoscopic, and Open Surgery: A Population-Based Cohort Study
| CANCER RESEARCH AND TREATMENT |
2021 | Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs
| YONSEI MEDICAL JOURNAL |
2021 | Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY |
2021 | Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix | MODERN PATHOLOGY |
2021 | A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer
| BRITISH JOURNAL OF CANCER |